Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Thyroid Neoplasms × Antibodies, Bispecific × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Thyroid Neoplasms 1 Metastatic Solid Tumors 1

Interventions

Sorafenib 8 lenvatinib 6 Everolimus 6 trametinib 5 dabrafenib 5 vandetanib 4 pembrolizumab 4 Sunitinib 4 Paclitaxel 4 Nivolumab 4 Magnetic Resonance Spectroscopy 4 Iodine-131 4 selpercatinib 3 apatinib 3 anlotinib 3 surufatinib 2 pazopanib 2 Vemurafenib 2 Triiodothyronine 2 Thyroxine 2 Thyrotropin Alfa 2 Surgical Procedures, Operative 2 Ipilimumab 2 Iodine-124 2 Doxorubicin 2 Docetaxel 2 Cyclophosphamide 2 Biopsy, Large-Core Needle 2 Axitinib 2 AZD 6244 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00467506 2011-11-11

RIT in MTC

Nantes University Hospital

Phase 2 Completed

Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡